Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

ImmunoTargets and therapy·2026
Same author

Biodiversity and biogeography of the multi-kingdom cancer microbiome.

Cell·2026
Same author

Linking Inflammation to Reduced Food Intake in Advanced Cancer: A Prospective Observational Study.

Current oncology (Toronto, Ont.)·2026
Same author

Effects of 5 Years of Aerobic Exercise on Sarcopenia in Older Adults-Secondary Outcomes of the Generation 100 Study.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Detecting microbial footprints in cancer sequencing.

Cancer cell·2026
Same author

Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer.

British journal of cancer·2026

相关实验视频

Updated: Jan 10, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.1K

癌症白内障中的血清miRNA签名取决于系统性炎症.

Terese Louise Schmidberger Karlsen1,2, Robin Mjelle2, Ola Magne Vagnildhaug1,2

  • 1Cancer Clinic, St. Olavs Hospital, 7030 Trondheim, Norway.

Current oncology (Toronto, Ont.)
|November 26, 2025
PubMed
概括

系统性炎症显著改变了癌症缓冲症患者的微RNA (miRNA) 概况,影响了生存率. 这些独特的miRNA签名表明了早期检测这种复杂综合征的潜在生物标志物.

关键词:
这就是米RNA.生物标志物 生物标志物卡赫西亚 (cachexia) 是一种失明的现象.癌症 癌症 癌症 癌症 癌症结肠直肠癌是什么意思这是一种炎症炎症炎症炎症.

更多相关视频

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.1K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.9K

相关实验视频

Last Updated: Jan 10, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.1K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.1K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.9K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 遗传学 是一个遗传学.

背景情况:

  • 癌症缓冲症是一种衰弱的综合征,其特点是不自发的体重和肌肉损失.
  • 系统性炎症是癌症缓冲症发展的关键驱动因素.
  • 了解缓解症背后的分子机制对于治疗的发展至关重要.

研究的目的:

  • 在患有结直肠癌的患者中调查循环的microRNA (miRNA) 概况.
  • 为了比较miRNA的个人资料,在有和没有症和全身炎症的患者之间.
  • 为了识别潜在的miRNA生物标志物用于癌症缓存症.

主要方法:

  • 一项多中心的纵向观察性研究,涉及168名无法切除结直肠癌的患者.
  • 根据卡赫克西亚和C反应性蛋白 (CRP) 水平,患者被分为四组.
  • 使用下一代测序分析了循环的miRNA配置文件.

主要成果:

  • 与没有这种情况的患者相比,患有白血病和全身炎症的患者显示出明显不同的miRNA配置文件.
  • 炎症性缓解症与较低的整体存活率相关 (HR 2.10,p < 0.001).
  • 在炎症性缓解症中发现了82种差异表达的miRNA,包括与肌肉质量和新陈代谢相关的miR-320家族,miR-6087,miR-4488,miR-29a-3p,miR-194-5p和miR-10a-5p.

结论:

  • 系统性炎症在癌症缓解症中起着关键作用,建议将其纳入诊断标准.
  • 循环的miRNAs代表了有前途的生物标志物,用于识别癌症缓存症.
  • 在炎症性缓冲症中,显著的miRNA概况突出显示了其生物特异性.